Beiersdorf
This article was originally published in The Rose Sheet
Executive Summary
Consumer business sales grew 5.2 % at current exchange rates, or 4% adjusted for currency effects, to $4.87 bil. (€1=$1.21) in fiscal 2005, German company notes in Jan. 10 preliminary earnings release. "Except for North America, all regions contributed positive growth rates," firm adds. Consumer EBIT was $560.8 mil. during the year, up 11%. Net sales at current exchange rates rose 5.1% in fiscal 2005 to $5.76 bil., or 3.9% adjusted for currency effects. Earnings before interest and taxes were up 11% to $633.2 mil., while profit after tax was approximately $398 mil. Beiersdorf will release final results March 2...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.